Avalo Therapeutics, Inc. · NASDAQ:AVTX

Caligan Partners LP reported a 5.90% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Caligan Partners LP reported a 5.90% stake in Avalo Therapeutics, Inc., 3,163,866 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
5.90%
Shares
3,163,866
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Caligan Partners LP5.90%3,163,866
David Johnson5.90%3,163,866

Source

View original at SEC

Related